So, Quizartinib is this FLT3 inhibitor thing. It’s mostly used for those AML patients who’ve had a rough go and have these FLT3-ITD mutations. It goes after the FLT3 receptor, blocking that FLT3 signaling thing.
That’s supposed to make treating AML a bit better. The recommended daily dose starts with a ramp-up, eventually reaching 53 mg for adults, available in two tablet strengths: 17.7 mg and 26.5 mg in film-coated format. Each pack is in a bottle with 28 tabs, so you just take one a day for the whole treatment thing.
Reviews
There are no reviews yet.